EP2271321
Lyfjasamsetning 271
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.3.2009EP published:
13.6.2012EP application number:
09726304.0
EP translation filed:
7.8.2012Grant published:
15.9.2012EPO information:
European Patent Register
Max expiry date:
25.3.2029Expiry date:
25.3.2027Next due date:
31.3.2027
Title:
PHARMACEUTICAL COMPOSITION 271
Timeline
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Name:
Array Biopharma, Inc.Address:
3200 Walnut Street, 80301, Boulder, CO, US
Inventor
Name:
BATEMAN, Nicola, FrancesAddress:
Cheshire SK10 2NA, GB
Name:
GELLERT, Paul, RichardAddress:
Cheshire SK10 4TG, GB
Name:
HILL, Kathryn, JaneAddress:
Cheshire SK10 4TG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
40372Date:
28.3.2008Country:
US
Classification
Categories:
A61K 9/48, A61K 9/14, A61K 31/4184, C07D 235/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.2.2013
Expires: 25.3.2014
Payer: Árnason Faktor
Number: 6
Paid: 7.2.2014
Expires: 25.3.2015
Payer: Árnason Faktor
Number: 7
Paid: 10.2.2015
Expires: 25.3.2016
Payer: Árnason Faktor
Number: 8
Paid: 10.2.2016
Expires: 25.3.2017
Payer: Árnason Faktor
Number: 9
Paid: 10.2.2017
Expires: 25.3.2018
Payer: Árnason Faktor
Number: 10
Paid: 8.2.2018
Expires: 25.3.2019
Payer: Árnason Faktor
Number: 11
Paid: 7.2.2019
Expires: 25.3.2020
Payer: Árnason Faktor
Number: 12
Paid: 18.2.2020
Expires: 25.3.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.2.2021
Expires: 25.3.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.2.2022
Expires: 25.3.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.2.2023
Expires: 25.3.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 14.2.2024
Expires: 25.3.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.3.2025
Expires: 25.3.2026
Payer: Árnason Faktor ehf.
Number: 18
Paid: 20.3.2026
Expires: 25.3.2027
Payer: Árnason Faktor ehf.